6550--supply - gene expression kits

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 has issued a Special Notice announcing its intent to award a sole source contract for gene expression reagent kits. The procurement, identified as solicitation number 36C24225Q0867, is specifically for Gene Expression reagent kits compatible with existing Genomics analyzer equipment at Mount Sinai Medical Center and James J. Peters VAMC in New York. The contract will be awarded to 10X Genomics, Inc. under the authority of 41 U.S.C. 253(c)(1), with the VA determining through market research that this sole source approach serves the government's best interests. The procurement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC code 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits And Sets. The contracting point of contact is Aleta Jennette at the VA Network Contracting Office in Bronx, NY.

The purpose of this Special Notice is to provide advance notification of the intended sole source award while allowing other potential vendors to submit Expressions of Interest (EOI) if they believe they can provide equivalent capabilities. Interested parties must submit their EOI via email to Aleta Jennette by 10:00 AM EST on July 28, 2025, providing detailed information about their capabilities, pricing, and technical data to demonstrate they could serve as alternative sources. The gene expression kits are specifically required for single-cell gene detection of rare transcript cell types, indicating a specialized scientific application within the VA medical facilities. While the government maintains sole discretion in determining whether to compete the proposed contract, this notice provides an opportunity for qualified vendors in the in-vitro diagnostic manufacturing sector to present their credentials. The procurement supports genomics research and diagnostic capabilities at two major VA medical centers in the New York area, contributing to advanced medical research and patient care within the Veterans Health Administration system.